Skip to content
← Full study record

NCT01222286 · MORE INFO

Limitations, agreements, and source contact

Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma · Source last updated 2026-05-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
renaud.buffet@innate-pharma.fr
organization
Innate Pharma
phone
33 4 30 30 30 32
title
Dr Renaud Buffet
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
renaud.buffet@innate-pharma.fr
organization
Innate Pharma
phone
33 4 30 30 30 32
title
Dr Renaud Buffet

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice